Trinidad and Tobago vs United Arab Emirates: HPV immunization coverage estimates among primary target cohort (9-14)
Trinidad and Tobago
41.0%
in 2025
United Arab Emirates
37.0%
in 2025
Trinidad and Tobago rank
100th
United Arab Emirates rank
101st
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Trinidad and Tobago
- United Arab Emirates
How they compare
Trinidad and Tobago currently reports 41.0% against 37.0% in United Arab Emirates, a difference of 4.0%.
That makes Trinidad and Tobago's figure about 1.1 times United Arab Emirates's.
The two have swapped places 2 times across 7 shared years of data; in 2018 it was Trinidad and Tobago ahead.
Trinidad and Tobago ranks 100th and United Arab Emirates ranks 101st of 111 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.5% | 25.5% | 2.0% | United Arab Emirates |
| 2020s | 30.6% | 40.0% | 9.4% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Trinidad and Tobago or United Arab Emirates?
- Trinidad and Tobago, at 41.0% against 37.0% in United Arab Emirates as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Trinidad and Tobago and United Arab Emirates?
- 4.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and United Arab Emirates?
- 7 years are reported by both, from 2018 to 2025.
- How do Trinidad and Tobago and United Arab Emirates rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Trinidad and Tobago ranks 100th and United Arab Emirates ranks 101st of 111 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.